Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy

被引:61
作者
Skopinski, P [1 ]
Rogala, E
Duda-Król, B
Lipinska, A
Sommer, E
Chorotowska-Wynimko, J
Szaflik, J
Partyka, I
Skopinska-Rózewska, E
机构
[1] Warsaw Med Univ, Fac Med 2, Dept Ophthalmol, Warsaw, Poland
[2] Warsaw Med Univ, Ctr Biostruct Res, Dept Histol & Embryol, Warsaw, Poland
[3] Natl Inst TB & Lung Dis, Dept Lung Dis 3, Warsaw, Poland
[4] Warsaw Med Univ, Fac Med 2, Dept Internal Med 3, Warsaw, Poland
[5] Warsaw Med Univ, Fac Dent, Dept Internal Med, Warsaw, Poland
[6] Natl Inst TB & Lung Dis, Dept Lab Diagnost & Immunol, Warsaw, Poland
[7] Warsaw Med Univ, Dept Pathol, Warsaw, Poland
关键词
diabetes type 2; background retinopathy; angiogenesis; interleukin-18;
D O I
10.1016/j.jdiacomp.2005.02.008
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Hyperglycaemia increases inflammatory cytokine concentration in the blood. Elevated levels of interleukin-18 (IL-18), a cytokine belonging to the interleukin-1 (IL-1) family, were recently reported in patients with Type 2 diabetes mellitus (DM2) and nephropathy. The aim of the present work was an examination of IL-18 concentration in the sera of elderly DM2 patients with nonproliferative retinopathy and age-matched control people and an estimation whether this cytokine plays pro- or anti-angiogenic role in in vivo angiogenic activity of their sera in mice cutaneous angiogenesis test. Recombinant human IL-18 injected intradermally to murine skin induced significant neovascular reaction. DM2 patients sera contained higher concentration of IL-1 8 and induced stronger neovascular reaction in mice skin than did the sera of corresponding control people. Sera from both groups of people after neutralization with antihuman IL-18 antibodies lost substantial part of their angiogenic activity. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:335 / 338
页数:4
相关论文
共 19 条
[1]
Interleukin-18 in multiple myeloma patients: serum levels in relation to response to treatment and survival [J].
Alexandrakis, MG ;
Passam, FH ;
Sfiridaki, K ;
Moschandrea, J ;
Pappa, C ;
Liapi, D ;
Petreli, E ;
Roussou, P ;
Kyriakou, DS .
LEUKEMIA RESEARCH, 2004, 28 (03) :259-266
[2]
Angiogenic activity and IL-8 concentrations in peritoneal fluid and sera in endometriosis [J].
Barcza, E ;
Rózewska, ES ;
Kaminski, P ;
Demkow, U ;
Bobrowska, K ;
Marianowski, L .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2002, 79 (03) :229-235
[3]
Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-β1) is a newly identified risk factor for proliferative diabetic retinopathy [J].
Beránek, M ;
Kanková, K ;
Benes, P ;
Izakovicová-Hollá, L ;
Znojil, V ;
Hájek, D ;
Vlková, E ;
Vácha, J .
AMERICAN JOURNAL OF MEDICAL GENETICS, 2002, 109 (04) :278-283
[4]
BRUIJN JA, 1994, J LAB CLIN MED, V123, P34
[5]
Interleukin-18 acts as an angiogenesis and tumor suppressor [J].
Cao, RH ;
Farnebo, J ;
Kurimoto, M ;
Cao, YH .
FASEB JOURNAL, 1999, 13 (15) :2195-2202
[6]
Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis [J].
Coughlin, CM ;
Salhany, KE ;
Wysocka, M ;
Aruga, E ;
Kurzawa, H ;
Chang, AE ;
Hunter, CA ;
Fox, JC ;
Trinchieri, G ;
Lee, WMF .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (06) :1441-1452
[7]
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress [J].
Esposito, K ;
Nappo, F ;
Marfella, R ;
Giugliano, G ;
Giugliano, F ;
Ciotola, M ;
Quagliaro, L ;
Ceriello, A ;
Giugliano, D .
CIRCULATION, 2002, 106 (16) :2067-2072
[8]
Interleukin-18: Perspectives on the newest interleukin [J].
Gillespie, MT ;
Horwood, NJ .
CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (02) :109-116
[9]
Urinary transforming growth factoro-β excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate -: Effects of angiotensin receptor blockade and sodium restriction [J].
Houlihan, CA ;
Akdeniz, A ;
Tsalamandris, C ;
Cooper, ME ;
Jerums, G ;
Gilbert, RE .
DIABETES CARE, 2002, 25 (06) :1072-1077
[10]
Lack of interferon-γ production despite the presence of interleukin-18 during cutaneous wound healing [J].
Kämpfer, H ;
Paulukat, J ;
Mühl, H ;
Wetzler, C ;
Pfeilschifter, J ;
Frank, S .
MOLECULAR MEDICINE, 2000, 6 (12) :1016-1027